Psychiatrist Dr. Amar Surdhar, M.D., founder of Clarion Psychiatry, has announced his support of the HAS Foundation, an organization dedicated to advancing neurological health through science, innovation, compassionate care and interdisciplinary collaboration. The announcement carries weight beyond a single philanthropic gesture: it places a practicing mental health clinician at the center of a broader effort to connect laboratory discovery with the daily realities of patients and families living with neurological disease and brain trauma.
The HAS Foundation addresses complex neurological and neurodegenerative conditions, including ALS, Alzheimer's disease, dementia and Parkinson's disease. Its model encourages collaboration among scientists, physicians, researchers, engineers, innovators and healthcare professionals, an approach that reflects a growing recognition that no single discipline can solve the challenges posed by brain disease. The Foundation's work extends beyond symptom management, emphasizing research, rehabilitation, cognition, therapeutic innovation and whole-person care while seeking to connect emerging scientific discoveries with clinical applications that can improve quality of life.
For Dr. Surdhar, the decision to support the Foundation reflects a shared belief that medicine must address not only illness but also the dignity, humanity and overall well-being of every patient. "As a psychiatrist, I have seen how profoundly conditions affecting the brain can impact not only an individual, but an entire family," Dr. Surdhar said. "I chose to support the HAS Foundation because its mission recognizes that meaningful progress requires science, innovation and compassion working together." He added that psychiatry is deeply connected to understanding the brain, human behavior and quality of life, and that supporting an organization committed to advancing neurological health, recovery and innovative solutions is a natural extension of that commitment. "Every breakthrough brings us closer to giving patients and families greater hope, dignity and possibility."
The significance of the announcement lies partly in timing. Neurological and neurodegenerative diseases continue to present complex challenges for patients, caregivers and the medical community, with few curative options and heavy long-term burdens. By creating opportunities for interdisciplinary collaboration and connecting research, technology and clinical practice, the Foundation seeks to accelerate the translation of scientific discoveries into solutions that can make a tangible difference in patients' lives. That translation gap, often described as the distance between promising research and real-world care, is one of the most persistent obstacles in neurology.
Dr. Surdhar's contribution also highlights the role physicians, researchers, philanthropists and community leaders can play in supporting organizations working at the intersection of brain health, innovation, healing and human-centered care. His support joins the Foundation in championing a future in which individuals confronting neurological disease and brain trauma are met not only with better science and treatment possibilities, but also with compassion, resources and hope. For a field where progress is often measured in years and incremental gains, such backing can help sustain the collaborative infrastructure needed to move discoveries from the bench to the bedside.
